Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus

Overview of attention for article published in Circulation, July 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 6 public wall posts from 4 users.

In #T2DM and elevated risk of #CVD, canagliflozin reduced the risk of #CV death or hospitalized #HF across different pt…

In #T2DM and elevated risk of #CVD, canagliflozin reduced the risk of #CV death or hospitalized #HF across different pt…

In #T2DM and elevated risk of #CVD, canagliflozin reduced the risk of #CV death or hospitalized #HF across different pt…

CANVAS: CV benefits of canagliflozin may be enhanced in those w/#heartfailure #CIRCACC18 #ACC18 http://spr.ly/6188Dp8NM

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity, including 2 additional Facebook posts.